We back technically validated European HealthTech companies at the inflection point between public grant capital and institutional scale capital — the moment where thoughtful investment compounds most dramatically.
Sectors are selected for alignment between time-to-market, capital efficiency and commercial defensibility. We maintain flexibility but strongly prefer the combinations below.
Check size: €100K–€2M at Pre-Seed and Seed; €2M–€5M at Series A. Approximately 50% of fund capital reserved for follow-on rounds up to €10M per company.
Rapid deployment, early investment, shortest time to market.
Regulatory hurdles, prototype and clinical validation stage.
Deep tech, de-risked ventures with longer horizons.
Pan-European network of payers, hospitals and commercial partners.
Senior operators to complete founding teams at the right moment.
EU MDR, IVDR, AI Act and HTA pathway expertise from day one.
Freedom-to-operate, prosecution strategy, portfolio valuation.
Warm introductions to research hospitals and reference sites.
Structuring non-dilutive capital alongside equity rounds.
Cross-border commercial activation, not single-country plays.
Tight relationships with seed-stage and growth-stage specialists.
Institutional governance from seed round — not after Series B.
Our pipeline flows from premier European innovation frameworks — EIT Health, European Innovation Council, EIT KICs, European Digital Innovation Hubs, top university TTOs, HealthTech clusters, EU Chambers of Commerce and early-stage HealthTech funds we syndicate with.
Deep programmatic access built over a decade of operational leadership. EU’s Innovation Triangle is both dealflow source, and leverage for portfolio companies
Alignment with other EU complementary instruments
Direct relationships with tech-transfer offices and research institutions.
Referral partnerships with leading HealthTech-focused programmes.
Broad SME dealflow access via national chamber networks.
Syndicated dealflow with aligned pre-seed and seed specialists.
We review every inbound pitch. Early-stage founders who match the thesis above are welcome.
Submit your pitch